Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-03

Clinical Trial Update: LEU01101: Safety and Preliminary Efficacy of LEU011 in Solid Tumours. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial for LEU011 assesses safety and preliminary efficacy in solid tumors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEU011

Snippet

Sponsor: Leucid Bio | Conditions: Tumor, Solid | Phase 1, Phase 2 | Status: RECRUITING